Publications by authors named "Shelby E Hamm"

Prader-Willi Syndrome (PWS) is a human genetic condition that affects up to 1 in 10,000 live births. Affected infants present with hypotonia and developmental delay. Hyperphagia and increasing body weight follow unless drastic calorie restriction is initiated.

View Article and Find Full Text PDF

We tested the hypothesis that voluntary wheel running would complement microdystrophin gene therapy to improve muscle function in young mdx mice, a model of Duchenne muscular dystrophy. mdx mice injected with a single dose of AAV9-CK8-microdystrophin or vehicle at age 7 weeks were assigned to three groups: mdxRGT (run, gene therapy), mdxGT (no run, gene therapy), or mdx (no run, no gene therapy). Wild-type (WT) mice were assigned to WTR (run) and WT (no run) groups.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Shelby E Hamm"

  • - Shelby E Hamm's research focuses on the intersection of diet, exercise, and genetic therapies in various mouse models, with significant implications for human genetic conditions like Prader-Willi Syndrome and Duchenne muscular dystrophy.
  • - In a study on Prader-Willi Syndrome, Hamm found that dietary conjugated linoleic acid effectively reduced body weight and fat in mouse models, highlighting potential dietary interventions for managing hyperphagia and obesity associated with this condition.
  • - Additionally, her work on Duchenne muscular dystrophy demonstrated that voluntary wheel running, when combined with microdystrophin gene therapy, can enhance muscle function in mdx mice, suggesting that exercise may play a critical role in optimizing outcomes of genetic therapies.